Can a diabetes drug reduce the risk for colorectal cancer? Elizabeth Tracey reports
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Diabetes drugs known as GLP1 receptor agonists are much in the news for weight loss. Now a new study finds that when people with diabetes take them, their risk of colorectal cancer is reduced. Kimmel Cancer Center director William Nelson …
Can a diabetes drug reduce the risk for colorectal cancer? Elizabeth Tracey reports Read more »